Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Kawashima

Showing results (91-100 of 102) with videos related to

Pageof 11
Sort By:
Hemasphere|October 30, 2023
Patient-reported Outcomes and Quality of Life in Anemic and Symptomatic Patients With Myelofibrosis: Results From the MOMENTUM StudyRuben A Mesa, Claire Harrison, Jeanne M Palmer, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|June 16, 2026
Preoperative ALBI and APRI are independently associated with liver-related complications after curative-intent hepatectomyKizuki Yuza, Jun Kawashima, Christian Hobeika, et al.
Annals of Surgical Oncology|June 14, 2026
Tumor Burden Modifies the Prognostic Impact of Adequate Lymph Node Dissection in Patients Undergoing Curative-Intent Resection for Intrahepatic CholangiocarcinomaJun Kawashima, Kota Sahara, Kizuki Yuza, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|May 19, 2026
Risk-adjusted cumulative sum (RA-CUSUM) method for real time monitoring of surgical units performanceAndrea Baldo, Miho Akabane, Jun Kawashima, et al.
Annals of Surgical Oncology|July 9, 2025
Preoperative Systemic Immune-Inflammatory Index Predicts Occult Nodal Disease in Clinically Node-Negative Intrahepatic CholangiocarcinomaJun Kawashima, Miho Akabane, Mujtaba Khalil, et al.
The British Journal of Surgery|March 29, 2025
Tumour burden predicts outcomes after curative resection of multifocal intrahepatic cholangiocarcinomaJun Kawashima, Miho Akabane, Mujtaba Khalil, et al.
Annals of Surgical Oncology|January 31, 2025
A Composite Endpoint of Liver Surgery (CELS): Development and Validation of a Clinically Relevant Endpoint Requiring a Smaller Sample SizeJun Kawashima, Miho Akabane, Yutaka Endo, et al.
Annals of Surgical Oncology|April 15, 2025
Impact of Tumor Size on the Survival Benefit of Anatomic Versus Non-Anatomic Resection for Intrahepatic CholangiocarcinomaJun Kawashima, Miho Akabane, Mujtaba Khalil, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|February 16, 2025
Impact of intraoperative blood loss on postoperative morbidity after liver resection for primary and secondary liver cancerAbdullah Altaf, Miho Akabane, Mujtaba Khalil, et al.
Annals of Surgical Oncology|July 9, 2025
Oncological Resectability Criteria for Intrahepatic Cholangiocarcinoma: A Preoperative Framework for Multidisciplinary ManagementJun Kawashima, Miho Akabane, Selamawit Woldesenbet, et al.
Pageof 11

Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
Hemasphere|October 30, 2023
Patient-reported Outcomes and Quality of Life in Anemic and Symptomatic Patients With Myelofibrosis: Results From the MOMENTUM StudyRuben A Mesa, Claire Harrison, Jeanne M Palmer, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|June 16, 2026
Preoperative ALBI and APRI are independently associated with liver-related complications after curative-intent hepatectomyKizuki Yuza, Jun Kawashima, Christian Hobeika, et al.
Annals of Surgical Oncology|June 14, 2026
Tumor Burden Modifies the Prognostic Impact of Adequate Lymph Node Dissection in Patients Undergoing Curative-Intent Resection for Intrahepatic CholangiocarcinomaJun Kawashima, Kota Sahara, Kizuki Yuza, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|May 19, 2026
Risk-adjusted cumulative sum (RA-CUSUM) method for real time monitoring of surgical units performanceAndrea Baldo, Miho Akabane, Jun Kawashima, et al.
Annals of Surgical Oncology|July 9, 2025
Preoperative Systemic Immune-Inflammatory Index Predicts Occult Nodal Disease in Clinically Node-Negative Intrahepatic CholangiocarcinomaJun Kawashima, Miho Akabane, Mujtaba Khalil, et al.
The British Journal of Surgery|March 29, 2025
Tumour burden predicts outcomes after curative resection of multifocal intrahepatic cholangiocarcinomaJun Kawashima, Miho Akabane, Mujtaba Khalil, et al.
Annals of Surgical Oncology|January 31, 2025
A Composite Endpoint of Liver Surgery (CELS): Development and Validation of a Clinically Relevant Endpoint Requiring a Smaller Sample SizeJun Kawashima, Miho Akabane, Yutaka Endo, et al.
Annals of Surgical Oncology|April 15, 2025
Impact of Tumor Size on the Survival Benefit of Anatomic Versus Non-Anatomic Resection for Intrahepatic CholangiocarcinomaJun Kawashima, Miho Akabane, Mujtaba Khalil, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|February 16, 2025
Impact of intraoperative blood loss on postoperative morbidity after liver resection for primary and secondary liver cancerAbdullah Altaf, Miho Akabane, Mujtaba Khalil, et al.
Annals of Surgical Oncology|July 9, 2025
Oncological Resectability Criteria for Intrahepatic Cholangiocarcinoma: A Preoperative Framework for Multidisciplinary ManagementJun Kawashima, Miho Akabane, Selamawit Woldesenbet, et al.
Pageof 11